Apogee Therapeutics, Inc. ( APGE) - Stock Earnings
Stock symbol APGE is outdated, potentially delisted? Maybe it is available on other exchange?
APGE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
APGE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -69.4 million USD | — USD |
| 2026Q1 | -74.1 million USD | — USD |
| 2026Q2 | -85.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
APGE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -84.0 million USD | — USD |
| 2024 | -182.1 million USD | — USD |
| 2025 | -255.8 million USD | — USD |
| 2026 Est. | — | — |
APGE
Price: $135.07
52 week price:
Earnings Per Share: -4.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 8.4 billion